Progyny (PGNY) reported Q3 adjusted earnings late Tuesday of $0.40 per diluted share, up from $0.38 a year earlier.

Analysts polled by Capital IQ expected $0.37.

Revenue for the quarter ended Sept. 30 was $286.6 million, compared with $280.9 million a year earlier.

Analysts surveyed by Capital IQ expected $297.4 million.

For Q4, the company expects adjusted earnings per diluted share of $0.31 to $0.35 and revenue of $266.2 million to $281.2 million. Analysts surveyed by Capital IQ expect earnings of $0.37 on revenue of $284 million.

The company narrowed its 2024 adjusted diluted earnings per share forecast to $1.54 to $1.57 from $1.53 to $1.61 previously. Analysts surveyed by Capital IQ expect $1.57.

The company also trimmed its revenue guidance for the year to $1.14 billion to $1.15 billion from $1.17 billion to $1.20 billion. Analysts polled by Capital IQ expect $1.15 billion.